Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Medical Research Journal
MENU
Shortcuts Submit an article Author Guidelines Reviewers 2023 Focus and Scope

open access

Vol 7, No 2 (2022)
Review article
Published online: 2022-06-14
View PDF Download PDF file
Get Citation

Critical considerations in management of patients with left ventricular assist device in an Emergency Department practice

Tomasz Kłosiewicz1, Mateusz Mazur2, Radosław Zalewski1, Roland Podlewski1, Witold Jurczyk1, Mateusz Puślecki13
DOI: 10.5603/MRJ.a2022.0025
·
Medical Research Journal 2022;7(2):170-175.
Affiliations
  1. Department of Medical Rescue, Faculty of Health Sciences, Poznan University of Medical Sciences, Poznan, Poland
  2. Department of Emergency Medicine, Faculty of Health Sciences, Poznan University of Medical Sciences, Poznan, Poland
  3. Department of Cardiac Surgery and Transplantology, Medical Faculty, Poznan University of Medical Sciences, Poznan, Poland

open access

Vol 7, No 2 (2022)
REVIEW ARTICLES
Published online: 2022-06-14

Abstract

In recent years, mechanical circulatory support has become an increasingly used treatment strategy for end-stage heart failure. Due to technological progress and higher availability of this therapy, the number of patients receiving left ventricular assist devices (LVAD) is increasing. A natural consequence of this is occurrence of complications related to this therapy. A patient presenting to an emergency department (ED) expects the highest level of care. Emergency department staff should have basic knowledge and skills to provide initial diagnostic and therapeutic interventions for patients with LVAD in life-threatening conditions. The most common reasons for patients with LVADs presenting to the ED are bleeding, heart rhythm disorders, stroke, or infections. This article aims to present the basic information that may be useful during the first medical contact in an emergency department. The authors have discussed the issue of diagnosis, and differences in laboratory findings and indicate where to best seek help. The article is dedicated to physicians, nurses, and paramedics working in emergency departments.

Abstract

In recent years, mechanical circulatory support has become an increasingly used treatment strategy for end-stage heart failure. Due to technological progress and higher availability of this therapy, the number of patients receiving left ventricular assist devices (LVAD) is increasing. A natural consequence of this is occurrence of complications related to this therapy. A patient presenting to an emergency department (ED) expects the highest level of care. Emergency department staff should have basic knowledge and skills to provide initial diagnostic and therapeutic interventions for patients with LVAD in life-threatening conditions. The most common reasons for patients with LVADs presenting to the ED are bleeding, heart rhythm disorders, stroke, or infections. This article aims to present the basic information that may be useful during the first medical contact in an emergency department. The authors have discussed the issue of diagnosis, and differences in laboratory findings and indicate where to best seek help. The article is dedicated to physicians, nurses, and paramedics working in emergency departments.

Full Text:

View PDF Download PDF file
Get Citation

Keywords

left ventricular assist device, emergency department, heart failure, emergency treatment, emergency nursing

About this article
Title

Critical considerations in management of patients with left ventricular assist device in an Emergency Department practice

Journal

Medical Research Journal

Issue

Vol 7, No 2 (2022)

Article type

Review article

Pages

170-175

Published online

2022-06-14

Page views

4404

Article views/downloads

461

DOI

10.5603/MRJ.a2022.0025

Bibliographic record

Medical Research Journal 2022;7(2):170-175.

Keywords

left ventricular assist device
emergency department
heart failure
emergency treatment
emergency nursing

Authors

Tomasz Kłosiewicz
Mateusz Mazur
Radosław Zalewski
Roland Podlewski
Witold Jurczyk
Mateusz Puślecki

References (35)
  1. Lloyd-Jones D, Adams RJ, Brown TM, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation. 2010; 121(7): 948–954.
    CrossRefPubMed
  2. van Riet EES, Hoes AW, Wagenaar KP, et al. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail. 2016; 18(3): 242–252.
    CrossRefPubMed
  3. Jones NR, Roalfe AK, Adoki I, et al. Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis. Eur J Heart Fail. 2019; 21(11): 1306–1325.
    CrossRefPubMed
  4. Gustafsson F, Rogers JG. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes. Eur J Heart Fail. 2017; 19(5): 595–602.
    CrossRefPubMed
  5. EUROMACS Report. http://www.euromacs.org/files/13/file/EUROMACS_NEWSLETTER_No_10.pdf (25.03.2022).
  6. Schweiger M, Vierecke J, Stiegler P, et al. Prehospital care of left ventricular assist device patients by emergency medical services. Prehosp Emerg Care. 2012; 16(4): 560–563.
    CrossRefPubMed
  7. McDonagh TA, Metra M, Adamo M, et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36): 3599–3726.
    CrossRefPubMed
  8. Tainter CR, Braun OÖ, Teran F, et al. Emergency department visits among patients with left ventricular assist devices. Intern Emerg Med. 2018; 13(6): 907–913.
    CrossRefPubMed
  9. Goebel M, Tainter C, Kahn C, et al. An urban 9-1-1 system's experience with left ventricular assist device patients. Prehosp Emerg Care. 2019; 23(4): 560–565.
    CrossRefPubMed
  10. Zieliński T, Wspomaganie lewokomorowe – metoda o rosnącym znaczeniu w leczeniu zaawansowanej niewydolności serca. Kardiologia po dyplomie. 2018; 3. https://podyplomie.pl/kardiologia/30603,wspomaganie-lewokomorowe-metoda-o-rosnacym-znaczeniu-w-leczeniu-zaawansowanej-niewydolnosci-serca (25.03.2022).
  11. Hockstein MA. Continuous-flow left ventricular assist devices: Management in the emergency department. J Am Coll Emerg Physicians Open. 2020; 1(4): 362–370.
    CrossRefPubMed
  12. Draper KV, Huang RJ, Gerson LB. GI bleeding in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis. Gastrointest Endosc. 2014; 80(3): 435–446.e1.
    CrossRefPubMed
  13. Peberdy MA, Gluck JA, Ornato JP, et al. American Heart Association Emergency Cardiovascular Care Committee, Council on Cardiopulmonary, Critical Care, Perioperative, and Resuscitation, Council on Cardiovascular Diseases in the Young, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology. Cardiopulmonary Resuscitation in Adults and Children With Mechanical Circulatory Support: A Scientific Statement From the American Heart Association. Circulation. 2017; 135(24): e1115–e1134.
    CrossRefPubMed
  14. Kociol RD, Pang PS, Gheorghiade M, et al. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol. 2010; 56(14): 1071–1078.
    CrossRefPubMed
  15. Ahmad T, Wang T, O'Brien EC, et al. Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury. JACC Heart Fail. 2015; 3(1): 30–39.
    CrossRefPubMed
  16. Darling CE, Martindale JL, Hiestand BC, et al. An emergency medicine-focused summary of the HFSA/SAEM/ISHLT clinical consensus document on the emergency management of patients with ventricular assist devices. Acad Emerg Med. 2020; 27(7): 618–629.
    CrossRefPubMed
  17. Feldman D, Pamboukian SV, Teuteberg JJ, et al. International Society for Heart and Lung Transplantation. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013; 32(2): 157–187.
    CrossRefPubMed
  18. Howell AJ, Ashkanase JL, Laks JA, et al. Sustained ventricular fibrillation in a conscious pediatric LVAD patient. The Journal of Heart and Lung Transplantation. 2021; 40(4): S535–S536.
    CrossRef
  19. Goldstein DJ, John R, Salerno C, et al. Algorithm for the diagnosis and management of suspected pump thrombus. J Heart Lung Transplant. 2013; 32(7): 667–670.
    CrossRefPubMed
  20. Mehra MR, Goldstein DJ, Uriel N, et al. MOMENTUM 3 Investigators. Two-Year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med. 2018; 378(15): 1386–1395.
    CrossRefPubMed
  21. Stulak JM, Lee D, Haft JW, et al. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device. J Heart Lung Transplant. 2014; 33(1): 60–64.
    CrossRefPubMed
  22. Stern DR, Kazam J, Edwards P, et al. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. J Card Surg. 2010; 25(3): 352–356.
    CrossRefPubMed
  23. Demirozu ZT, Radovancevic R, Hochman LF, et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2011; 30(8): 849–853.
    CrossRefPubMed
  24. Malik S, Malik SA, Ulmer LL, et al. Gastrointestinal bleeding with left ventricular assist devices (LVAD): locating the leak and identifying outcomes. J Clin Gastroenterol. 2019; 53(5): e202–e207.
    CrossRefPubMed
  25. Uriel N, Pak SW, Jorde UP, et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010; 56(15): 1207–1213.
    CrossRefPubMed
  26. Kim JuH, Brophy DF, Shah KB. Continuous-Flow Left Ventricular Assist Device-Related Gastrointestinal Bleeding. Cardiol Clin. 2018; 36(4): 519–529.
    CrossRefPubMed
  27. Dang G, Grayburn R, Lamb G, et al. Octreotide for the management of gastrointestinal bleeding in a patient with a heartware left ventricular assist device. Case Rep Cardiol. 2014; 2014: 826453.
    CrossRefPubMed
  28. Gurvits GE, Fradkov E. Bleeding with the artificial heart: gastrointestinal hemorrhage in CF-LVAD patients. World J Gastroenterol. 2017; 23(22): 3945–3953.
    CrossRefPubMed
  29. Frontera JA, Starling R, Cho SM, et al. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices. J Heart Lung Transplant. 2017; 36(6): 673–683.
    CrossRefPubMed
  30. Mabvuure NT, Rodrigues JN. External cardiac compression during cardiopulmonary resuscitation of patients with left ventricular assist devices. Interact Cardiovasc Thorac Surg. 2014; 19(2): 286–289.
    CrossRefPubMed
  31. Shinar Z, Bellezzo J, Stahovich M, et al. Chest compressions may be safe in arresting patients with left ventricular assist devices (LVADs). Resuscitation. 2014; 85(5): 702–704.
    CrossRefPubMed
  32. Yarboro LT, Bergin JD, Kennedy JLW, et al. Technique for minimizing and treating driveline infections. Ann Cardiothorac Surg. 2014; 3(6): 557–562.
    CrossRefPubMed
  33. Pavlovic NV, Randell T, Madeira T, et al. Risk of left ventricular assist device driveline infection: A systematic literature review. Heart Lung. 2019; 48(2): 90–104.
    CrossRefPubMed
  34. Bowles CT, Hards R, Wrightson N, et al. Algorithms to guide ambulance clinicians in the management of emergencies in patients with implanted rotary left ventricular assist devices. Emerg Med J. 2017; 34(12): 842–850.
    CrossRefPubMed
  35. Bowles C. Left ventricular assist devices in the community. Perfusion. 2000; 15(4): 373–374.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl